drugset / Trial / NCT00130468

TREAD-20: Trial of Hyalgan Three Injection-Regimen for the Treatment of Knee Pain Due to Osteoarthritis

NCT00130468

Phase 4 Completed 150 enrolled Sanofi
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will evaluate the efficacy and safety of intra-articular injections of 20 mg/2mL dose HYALGAN in patients with pain due to osteoarthritis (OA) of the knee.

Timeline

Start
2004-11
Primary completion
Completion
2006-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Sodium Hyaluronate Other / unclassified 20 mg Other

Indications